NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

You will have no idea whether the “used the”’time well regardless of the journal, but I don’t but they wasted time. Assuming things is part of the game around here. And people will find ways to create disappointment regardless of where, how or when. That is how some people’s constitution works.

What matters is what comes of it. Many articles, even in big journals, don’t necessarily have the anticipated impact on a price, or change a paradigm on pricing substantially for these tiny cell therapy companies. What will change is the longer term outlook. Some may try to suppress gains, as we have seen in the past. What matters, however is the ultimate full picture of validation and then take-up of the treatment as a new standard of care.